How is the Adaptive Biotechnologies Corp today?

The Adaptive Biotechnologies Corp today is trading in the down by -0.96% at 10.31.

How has Adaptive Biotechnologies Corp performed historically?

The Adaptive Biotechnologies Corp is currently trading down -0.96% on an intraday basis in the past week the index rose 4.46%. The index has been up 35.30% in the past quarter and rose 197.98% in the past year. You can view this in the overview section.

What is Adaptive Biotechnologies Corp Annual Revenue?

Adaptive Biotechnologies Corp Annual Revenue rose 5.1%, in the last year to $178.96 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Adaptive Biotechnologies Corp Annual Net Profit?

Adaptive Biotechnologies Corp Annual Net Profit rose 29.19% in the last year to $159.49 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Adaptive Biotechnologies Corp Price to Earning Ratio?

Adaptive Biotechnologies Corp Price to Earning Ratio is -11.04, which is negative.

What is Adaptive Biotechnologies Corp Stock Price?

Adaptive Biotechnologies Corp Stock Price rose 197.98% and outperformed its sector by 172.4% in the past year.

What is Adaptive Biotechnologies Corp Quarterly Revenue?

Adaptive Biotechnologies Corp Quarterly Revenue rose 25.24% YoY to $52.44 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Adaptive Biotechnologies Corp Quarterly Net profit?

Adaptive Biotechnologies Corp Quarterly Net profit rose 37.16% YoY to $29.85 M. Its sector's average net profit growth YoY for the quarter was -238.58%.

What is Adaptive Biotechnologies Corp Debt to Equity Ratio?

Adaptive Biotechnologies Corp Debt to Equity Ratio of 0.44 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Adaptive Biotechnologies Corp Return on Equity(ROE)?

Adaptive Biotechnologies Corp Return on Equity(ROE) for the last financial year was -62.41%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Adaptive Biotechnologies Corp Mutual Fund Holding?

Adaptive Biotechnologies Corp Mutual Fund Holding increased by 4.25% in the last quarter to 60.83.

What is Adaptive Biotechnologies Corp Promoter Share Holding?

Adaptive Biotechnologies Corp Promoter Share Holding increased by 0.88% in the most recent quarter to 5.18%.

What is Adaptive Biotechnologies Corp Interest Coverage Ratio?

Adaptive Biotechnologies Corp Interest Coverage Ratio is -12.78, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Adaptive Biotechnologies Corp Institutional Holding?

Adaptive Biotechnologies Corp Institutional Holding increased by 4.98% in the last quarter to 100.15.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
ADAPTIVE BIOTECHNOLOGIES CORP

Adaptive Biotechnologies Corp XNAS: ADPT

Adaptive Biotechnologies Corp Live Share Price Today, Share Analysis and Chart

Name: Adaptive Biotechnologies Corp: Is Infosys Ltd. worth buying?
Item: Adaptive Biotechnologies Corp
Rating: 1.7109445
Author: Trendlyne DVM scores

Momentum Trap

about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

10.31 -0.10 (-0.96%)

New 52W High in past week

624.7K

XNAS Volume

XNAS 13 Jun, 2025 3:40 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

9.5 / 100

Technically Bullish

71.8 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

1Yr Price target upside is 10%

6 analysts

Adaptive Biotechnologies Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptive Biotechnologies Corp Live Share Price Today, Share Analysis and Chart

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

New 52W High in past week

SWOT Analysis

Adaptive Biotechnologies Corp Live Price Chart

Adaptive Biotechnologies Corp FAQ

How is Adaptive Biotechnologies Corp today?

Adaptive Biotechnologies Corp today is trading in the red, and is down by -0.96% at 10.31.

How has Adaptive Biotechnologies Corp performed historically?

Adaptive Biotechnologies Corp is currently trading down -0.96% on an intraday basis. In the past week the stock rose 4.46%. stock has been up 35.30% in the past quarter and rose 197.98% in the past year. You can view this in the overview section.